HSPG2 and central nervous system cancer: Notably, EGFRvIII-expressing glioma cells may promote increased expression of PKC [28], the downstream effector enzyme of PLC, which is known to be a modulator of the ERK signalling cascade and is involved in glioma cell migration [118,119].